Kaplan-Meier survival curves indicated that patients with high expression of ERCC6L and MYB had significantly longer survival than those with low expression (P < 0.05) (Supplementary Figure S1), suggesting that high expression of these two genes may be associated with improved prognosis in gastric cancer patients. The gene discussed is ERCC6L; the disease is gastric cancer.